Ferro VA - Search Results

1

Delivering natural products and biotherapeutics to improve drug efficacy.

Obeid MA, Al Qaraghuli MM, Alsaadi M, Alzahrani AR, Niwasabutra K, Ferro VA. Obeid MA, et al. Among authors: ferro va. Ther Deliv. 2017 Nov;8(11):947-956. doi: 10.4155/tde-2017-0060. Ther Deliv. 2017. PMID: 29061102 Free article.

2

Optimizing efficacy of mucosal vaccines.

Gebril A, Alsaadi M, Acevedo R, Mullen AB, Ferro VA. Gebril A, et al. Among authors: ferro va. Expert Rev Vaccines. 2012 Sep;11(9):1139-55. doi: 10.1586/erv.12.81. Expert Rev Vaccines. 2012. PMID: 23151169 Review.

3

Assessment of the antigen-specific antibody response induced by mucosal administration of a GnRH conjugate entrapped in lipid nanoparticles.

Gebril AM, Lamprou DA, Alsaadi MM, Stimson WH, Mullen AB, Ferro VA. Gebril AM, et al. Among authors: ferro va. Nanomedicine. 2014 Jul;10(5):971-9. doi: 10.1016/j.nano.2013.12.005. Epub 2013 Dec 27. Nanomedicine. 2014. PMID: 24374362

4

Fertility control in wildlife: review of current status, including novel and future technologies.

Garside D, Gebril A, Alsaadi M, Ferro VA. Garside D, et al. Among authors: ferro va. Adv Exp Med Biol. 2014;753:467-88. doi: 10.1007/978-1-4939-0820-2_18. Adv Exp Med Biol. 2014. PMID: 25091920 Review.

5

The effects of hydration media on the characteristics of non-ionic surfactant vesicles (NISV) prepared by microfluidics.

Obeid MA, Khadra I, Mullen AB, Tate RJ, Ferro VA. Obeid MA, et al. Among authors: ferro va. Int J Pharm. 2017 Jan 10;516(1-2):52-60. doi: 10.1016/j.ijpharm.2016.11.015. Epub 2016 Nov 9. Int J Pharm. 2017. PMID: 27836752 Free article.

6

Analysis of the binding loops configuration and surface adaptation of different crystallized single-domain antibodies in response to various antigens.

Al Qaraghuli MM, Ferro VA. Al Qaraghuli MM, et al. Among authors: ferro va. J Mol Recognit. 2017 Apr;30(4). doi: 10.1002/jmr.2592. Epub 2016 Nov 16. J Mol Recognit. 2017. PMID: 27862476 Free article.

7

Comparison of the physical characteristics of monodisperse non-ionic surfactant vesicles (NISV) prepared using different manufacturing methods.

Obeid MA, Gebril AM, Tate RJ, Mullen AB, Ferro VA. Obeid MA, et al. Among authors: ferro va. Int J Pharm. 2017 Apr 15;521(1-2):54-60. doi: 10.1016/j.ijpharm.2017.02.007. Epub 2017 Feb 3. Int J Pharm. 2017. PMID: 28163227 Free article.

8

Formulation of Nonionic Surfactant Vesicles (NISV) Prepared by Microfluidics for Therapeutic Delivery of siRNA into Cancer Cells.

Obeid MA, Elburi A, Young LC, Mullen AB, Tate RJ, Ferro VA. Obeid MA, et al. Among authors: ferro va. Mol Pharm. 2017 Jul 3;14(7):2450-2458. doi: 10.1021/acs.molpharmaceut.7b00352. Epub 2017 Jun 8. Mol Pharm. 2017. PMID: 28570823 Free article.

9

Proof of concept studies for siRNA delivery by nonionic surfactant vesicles: in vitro and in vivo evaluation of protein knockdown.

Obeid MA, Dufès C, Somani S, Mullen AB, Tate RJ, Ferro VA. Obeid MA, et al. Among authors: ferro va. J Liposome Res. 2019 Sep;29(3):229-238. doi: 10.1080/08982104.2018.1531424. Epub 2019 Jan 1. J Liposome Res. 2019. PMID: 30296860

10

Exosomes: fighting cancer with cancer.

Alyamani H, Obeid MA, Tate RJ, Ferro VA. Alyamani H, et al. Among authors: ferro va. Ther Deliv. 2019 Jan;10(1):37-61. doi: 10.4155/tde-2018-0051. Ther Deliv. 2019. PMID: 30730823 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

91 results

Search Page